Biolargo Inc (BLGO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.2627 +0.0076 (+2.98%) 03/18/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.2627 unch (unch) 15:49 ET
for Tue, Mar 18th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 3,539 | 1,851 | 962 | 716 | 655 |
Receivables | 2,612 | 1,064 | 513 | 484 | 355 |
Inventories | 153 | 120 | 241 | 277 | 16 |
TOTAL | $6,362 | $3,153 | $1,801 | $1,505 | $1,065 |
Non-Current Assets | |||||
PPE Net | 662 | 287 | 61 | 60 | 95 |
Investments And Advances | 19 | 33 | 48 | 63 | 0 |
Other Non-Current Assets | 1,162 | 1,385 | 1,113 | 3,314 | 2,461 |
TOTAL | $1,843 | $1,705 | $1,222 | $3,437 | $2,556 |
Total Assets | $8,205 | $4,858 | $3,023 | $4,942 | $3,621 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 66 | 100 | 314 | 1,102 | 4,057 |
Accounts payable and accrued liabilities | 1,885 | 1,178 | 789 | 1,049 | 602 |
Other current liabilities | 420 | 201 | 79 | N/A | N/A |
TOTAL | $2,710 | $1,576 | $1,374 | $3,544 | $4,354 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | 261 | 187 | N/A | N/A |
Deferred Revenues | N/A | N/A | 89 | 48 | 35 |
aiOther Non-Current Liabilities | 2,437 | 1,669 | 343 | 2,901 | 2,197 |
TOTAL | $1,293 | $1,271 | $716 | $1,633 | $1,447 |
Total Liabilities | $4,003 | $2,847 | $2,090 | $5,177 | $5,801 |
Shareholders' Equity | |||||
Shares Outstanding, K | 295,553 | 283,192 | 262,723 | 238,776 | 172,336 |
Common Shares | 196 | 186 | 171 | 151 | 111 |
Retained earnings | -147,098 | -143,594 | -139,121 | -132,041 | -123,492 |
Other shareholders' equity | -2,919 | -3,016 | -3,835 | -4,194 | -126 |
TOTAL | $4,202 | $2,011 | $933 | $-235 | $-2,180 |
Total Liabilities And Equity | $8,205 | $4,858 | $3,023 | $4,942 | $3,621 |